UA117907C2 - Лікування припинення пологів - Google Patents

Лікування припинення пологів

Info

Publication number
UA117907C2
UA117907C2 UAA201411545A UAA201411545A UA117907C2 UA 117907 C2 UA117907 C2 UA 117907C2 UA A201411545 A UAA201411545 A UA A201411545A UA A201411545 A UAA201411545 A UA A201411545A UA 117907 C2 UA117907 C2 UA 117907C2
Authority
UA
Ukraine
Prior art keywords
treatment
labor
arrest
labor arrest
sulfated
Prior art date
Application number
UAA201411545A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ґунвор Екман-Ордеберг
Андерс Мальмстрьом
Original Assignee
Ділафор Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ділафор Аб filed Critical Ділафор Аб
Publication of UA117907C2 publication Critical patent/UA117907C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
UAA201411545A 2012-03-26 2013-03-25 Лікування припинення пологів UA117907C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (1)

Publication Number Publication Date
UA117907C2 true UA117907C2 (uk) 2018-10-25

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201411545A UA117907C2 (uk) 2012-03-26 2013-03-25 Лікування припинення пологів

Country Status (15)

Country Link
US (1) US20150057226A1 (enExample)
EP (1) EP2830634A4 (enExample)
JP (1) JP2015514705A (enExample)
CN (1) CN104244957B (enExample)
AU (1) AU2013240598A1 (enExample)
CA (1) CA2868479A1 (enExample)
HK (1) HK1203370A1 (enExample)
MX (1) MX2014011451A (enExample)
MY (1) MY185108A (enExample)
NZ (1) NZ631279A (enExample)
RU (1) RU2014143008A (enExample)
SG (1) SG11201406118QA (enExample)
UA (1) UA117907C2 (enExample)
WO (1) WO2013147690A1 (enExample)
ZA (1) ZA201406567B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
SMT201800143T1 (it) 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico
SG10201607872PA (en) 2012-03-26 2016-11-29 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
CA2868403A1 (en) * 2012-05-08 2013-11-14 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
KR20220142508A (ko) 2020-02-17 2022-10-21 딜라포 아베 자간전증 치료용 타폭시파린
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AU2024213271A1 (en) * 2023-02-01 2025-07-17 Materna Medical, Inc. Methods and apparatus for preventing vaginal lacerations during childbirth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
SMT201800143T1 (it) * 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico

Also Published As

Publication number Publication date
AU2013240598A1 (en) 2014-10-02
CA2868479A1 (en) 2013-10-03
HK1203370A1 (en) 2015-10-30
SG11201406118QA (en) 2014-11-27
WO2013147690A1 (en) 2013-10-03
MX2014011451A (es) 2014-11-10
EP2830634A1 (en) 2015-02-04
NZ631279A (en) 2016-06-24
JP2015514705A (ja) 2015-05-21
MY185108A (en) 2021-04-30
CN104244957A (zh) 2014-12-24
CN104244957B (zh) 2017-11-17
ZA201406567B (en) 2017-06-28
US20150057226A1 (en) 2015-02-26
RU2014143008A (ru) 2016-05-20
EP2830634A4 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
MY185108A (en) Method for treatment of labor arrest
PH12019501197A1 (en) Therapeutically active compounds and their methods of use
MX2015014582A (es) Agentes para regulacion hacia abajo de la actividad y/o cantidad de bcl-xl y/o bcl-w.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
PH12016500164B1 (en) Therapeutically active compounds and their methods of use
PH12014501561A1 (en) Therapeutically active compounds and their methods of use
IL239488A0 (en) A gpc3-targeted medicinal agent for the treatment of patients for whom treatment with a gpc3-targeted medicinal agent is beneficial
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
MX364220B (es) Metodos de tratamientos de fibrosis.
HK1223924A1 (zh) 治疗活性化合物及其使用方法
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
MY175743A (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
PH12015500663A1 (en) Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents
SI3125865T1 (sl) Povezava aktivnih sestavin za lokalno uporabo pri prestrukturiranju spremenjene kožne pregrade ki sledi kožnim boleznim
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
IN2014MN02461A (enExample)
MY192330A (en) Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
UA97741C2 (ru) Способ восстановления кожных покровов при глубоких распространенных ожогах микроаутодермотрансплантатами
UA61823U (ru) Применение гамма-оксимасляной кислоты как стимулятора ускорения скорости регенерации и восстановления силы мышечных сокращений
IN2013MU02732A (enExample)
FR2975597B1 (fr) Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes